We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Globe Life (GL) to Report Q1 Earnings: What's in Store?
Read MoreHide Full Article
Globe Life Inc. (GL - Free Report) is slated to report first-quarter 2020 results on Apr 22, after the closing bell.
Q1 Earnings & Revenue Expectations
The Zacks Consensus Estimate for first-quarter revenues is pegged at $1.2 billion, suggesting an improvement of 4.8% from the prior-year quarter.
The same for earnings per share is pegged at $1.73 cents, indicating growth of 5.5% from the year-ago reported figure.
Key Factors for Q1 Earnings
Globe Life first-quarter performance is likely to have benefited from higher premiums derived from its life and health insurance businesses. Thereby, the Zacks Consensus Estimate for first-quarter 2020 total premiums is pegged at $944 million, indicating an improvement of 5.9% from the year-ago quarter. Notably, first-quarter life and health premiums are pegged at $658 million and $286 million, respectively, suggesting growth of 5.4% and 7.1%, respectively, from the prior-year quarter.
Strength in net investment income is likely have bolstered Globe Life’s performance in the to-be-reported quarter. The Zacks Consensus Estimate for first-quarter net investment income stands at $230 million, which indicates an improvement of 1.3% from the year-ago reported figure.
Efficient performance across all distribution channels is likely to have benefited the company’s underwriting results in the to-be-reported quarter. Share buybacks made by Globe Life are likely to have provided an additional boost to the first-quarter performance.
However, increased expenses due to higher healthcare and employee pension costs are likely to have impacted the first-quarter performance.
Earnings Surprise History
The company has beat estimates in three of the trailing four quarters. It has a trailing four-quarter positive earnings surprise of 1.24%, on average.
Our proven model does not conclusively predict an earnings beat for Globe Life this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here.
Earnings ESP: Globe Life has an Earnings ESP of -0.43%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Some stocks worth considering from the finance sector with a perfect mix of elements to surpass estimates in the upcoming quarterly releases are as follows:
Virtu Financial, Inc. (VIRT - Free Report) has an Earnings ESP of +41.57% and a Zacks Rank #1. The company is slated to announce first-quarter 2020 earnings on May 7.
CURO Group Holdings Corp. has an Earnings ESP of +1.47% and a Zacks Rank #1. The company is scheduled to release first-quarter 2020 earnings on Apr 30.
Nasdaq, Inc. (NDAQ - Free Report) has an Earnings ESP of +1.15 % and a Zacks Rank of 3. The company is set to report first-quarter 2020 earnings on Apr 22.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Globe Life (GL) to Report Q1 Earnings: What's in Store?
Globe Life Inc. (GL - Free Report) is slated to report first-quarter 2020 results on Apr 22, after the closing bell.
Q1 Earnings & Revenue Expectations
The Zacks Consensus Estimate for first-quarter revenues is pegged at $1.2 billion, suggesting an improvement of 4.8% from the prior-year quarter.
The same for earnings per share is pegged at $1.73 cents, indicating growth of 5.5% from the year-ago reported figure.
Key Factors for Q1 Earnings
Globe Life first-quarter performance is likely to have benefited from higher premiums derived from its life and health insurance businesses. Thereby, the Zacks Consensus Estimate for first-quarter 2020 total premiums is pegged at $944 million, indicating an improvement of 5.9% from the year-ago quarter. Notably, first-quarter life and health premiums are pegged at $658 million and $286 million, respectively, suggesting growth of 5.4% and 7.1%, respectively, from the prior-year quarter.
Strength in net investment income is likely have bolstered Globe Life’s performance in the to-be-reported quarter. The Zacks Consensus Estimate for first-quarter net investment income stands at $230 million, which indicates an improvement of 1.3% from the year-ago reported figure.
Efficient performance across all distribution channels is likely to have benefited the company’s underwriting results in the to-be-reported quarter. Share buybacks made by Globe Life are likely to have provided an additional boost to the first-quarter performance.
However, increased expenses due to higher healthcare and employee pension costs are likely to have impacted the first-quarter performance.
Earnings Surprise History
The company has beat estimates in three of the trailing four quarters. It has a trailing four-quarter positive earnings surprise of 1.24%, on average.
Globe Life Inc. Price and EPS Surprise
Globe Life Inc. price-eps-surprise | Globe Life Inc. Quote
What Our Quantitative Model Predicts
Our proven model does not conclusively predict an earnings beat for Globe Life this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here.
Earnings ESP: Globe Life has an Earnings ESP of -0.43%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Globe Life carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to Consider
Some stocks worth considering from the finance sector with a perfect mix of elements to surpass estimates in the upcoming quarterly releases are as follows:
Virtu Financial, Inc. (VIRT - Free Report) has an Earnings ESP of +41.57% and a Zacks Rank #1. The company is slated to announce first-quarter 2020 earnings on May 7.
CURO Group Holdings Corp. has an Earnings ESP of +1.47% and a Zacks Rank #1. The company is scheduled to release first-quarter 2020 earnings on Apr 30.
Nasdaq, Inc. (NDAQ - Free Report) has an Earnings ESP of +1.15 % and a Zacks Rank of 3. The company is set to report first-quarter 2020 earnings on Apr 22.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>